Associations between Traditional Chinese Medicine Body Constitution and Cardiovascular Disease Risk in a White population

Introduction

In Traditional Chinese Medicine (TCM), a primary framework of health maintenance and surveillance hinges upon the classification of individuals into nine categories of “body constitutions” (BC): Gentleness type, Qi-deficiency type, Yang-deficiency type, Yin-deficiency type, Phlegm-dampness type, Dampness-heat type, Blood-stasis type, Qi-depression type, and Special diathesis type ¹. These BCs help to draw a picture of an individual’s health status and have been used on a provider-specific basis to identify patients who may be at risk for future disease, such as cardiovascular disease (CVD). However, TCM has a very limited role in Western medical practice and part of the reason for this is a simple lack of data concerning its application in Western populations. Additionally, while BCs are generally assigned based on different measures of an individual’s health, there exists little in the way of standardization when it comes to broadly applying this health framework in the clinical setting ^2-5. What is more, there have been few studies regarding the relationship between TCM principles and contemporary models of health and disease. For example, the BC types of Yin and Yang-deficiency, which describe individuals who are routinely hot/anxious or cold/sluggish, seem to hint at manifestations of thyroid disease. Despite these parallels, little has been done to study what possible relations may exist between the BC framework and our current understanding of health and disease. Studies of this kind may not only help us understand more about the BC principle, but may also establish a role for BCs in current medical practices, such as in diagnostic screens.

Su et al. developed the most commonly used questionnaire to stratify individuals into the 9 major BC types ^6,7. With this more standard approach, a number of studies have attempted to then explore utility of the TCM BC structure, specifically with the intent to identify a biological basis for the different BC types. In one particular study, associations between TCM BC types and HLA polymorphisms were identified ⁸. In a similar study, it was discovered that specific BC types are more likely to carry genetic variations of metabolic genes ⁹. These efforts represent attempts to ground the principles of the TCM BC framework in empiric data that explores physiologic and genetic bases for the different TCM BCs. This will in turn help identify clinical associations to chronic disease.

CVD is of particular interest in this study. It remains the leading cause of death worldwide, in particular due to its subtypes of coronary artery disease (CAD), as well as its manifestations of acute coronary syndrome (ACS) and myocardial infarction (MI) ^10,11. The landmark Framingham Heart study provided data to establish what are now well-known risk factors of CVD, including cigarette smoking, cholesterol, blood pressure, and others ¹². Understanding and identifying these risk factors have led to major advances in health maintenance, including the advent of routine blood pressure monitoring, regular exercise, and lipid control. Nonetheless, heart disease remains the leading cause of death in the US. Thus, there is a need to identify other early markers of CVD or populations at greatest risk to further preventive cardiology. The relationship of TCM BCs and markers of chronic disease, including dyslipidemia, hypertension, diabetes, etc., have further been studied and helped foster increased interest in the TCM BC system, as they might serve as an early indicator of needed intervention for specific chronic illnesses ^13-15.

However, all of these previous studies using TCM BC have been conducted in Chinese populations except for one study of 400 White college students attending three Beijing universities in China ¹⁶. In addition, none of the previous studies have examined the associations between TCM BCs and CVD risk. To that end, the aim of this study is to investigate the ability for TCM BCs to identify participants at higher risk for CVD per general cardiovascular risk score (GCRS), an updated version of the original Framingham risk score (FRS), in a US population of white individuals; whether TCM BC is a better correlate of biomarkers of CVD (C-reactive protein (CRP) and uric acid) ^17,18 than the GCRS; and whether TCM BC is associated with weight, body mass index and waist-to-hip ratio. In the same way that the Framingham study gave physicians insight on which health parameters may predict later heart disease, we seek to determine the potential value of utilizing TCM BCs in the clinical setting to predict CVD development ^19,20.

Materials and Methods

We conducted a cross-sectional study using baseline data from the Personalized Prevention of Colorectal Cancer Trial (PPCCT; NCT01105169 at ClinicalTrials.gov). The primary aim of the PPCCT was to examine the effect of Mg supplementation on expression of carcinogenesis biomarkers in colorectal mucosa. Between 2010 and 2017, the PPCCT enrolled 250 participants, aged 40 to 85 years, with high risk of colorectal cancer from Vanderbilt University Medical Center. Detailed inclusion and exclusion criteria have been reported (Supplemental materials) ^21,22. The study was approved by the Vanderbilt Institutional Review Board.

Results

For the reliability and validity of the self-administered Traditional Chinese Medicine Questionnaire (English Version), the construct validity was confirmed with scaling success rates that ranged from 75.0 to 100% (Supplemental Table 2), and confirmatory factor analysis indicate an acceptable model fit. The results of reliability for test-retest reliability (intra-class correlation coefficients) were 0.7-0.8 (Supplemental Table 3), the Cronbach’s alphas ranged from 0.44 to 0.72 during three-month period.

As shown in Table 1, the distribution of BC types varied greatly between this study and previous studies conducted in Chinese populations. Gentleness (29.8%) was the predominant BC type in this study, while the three most common pathologic BC types were Blood-stasis (17.3%), Qi-deficient (13.6%), and Special diathesis (10.5%). In contrast, the most common pathologic BC types found in Chinese populations, in no particular order, were Qi-deficient, Yang-deficient, Yin-deficient, and Phlegm-Dampness.

The characteristics of the study participants are shown overall and by BC type in Table 2. Among the 191 participants, the median age was 60, a minority were active smokers, and a majority were using anti-hypertensive and anti-lipid medications, both of which reflect a higher risk of CVD. There were statistically significant differences in the distribution of several factors across the various BC types. These included BMI, gender, CRP, and GCRS. Specifically, the Gentleness BC had a generally lower average BMI (28.9), CRP (2.2), and GCRS (20.6), as well as lower female predominance (26.3%) compared to other groups.

Discussion

All previous studies of BC type have been conducted in Chinese populations except for a study of White college students in China ¹⁶. The present study, to the best of our knowledge, is the first to be done in an American population ²⁶. The major types of TCM BC in our study of white individuals in the US were different from the types among Chinese in China. Furthermore, in this cross-sectional study, we newly examined the relationships between the nine BC types with predictive models or markers of CVD, in particular the GCRS.

Our study of white individuals in the US had a large proportion of Blood-Stasis (17.3%) and Special Diathesis types (10.5%). No previous study has been conducted in US populations. In a previous large study with 8,448 participants conducted within Chinese population, the most common pathologic BC subtypes are Qi-deficient (13.4%), Dampness-Heat (9.1%) and Yang-deficient (9.0%) ²⁷. The difference between our study of white individuals in the US and this large study conducted in Chinese population may be due to multiple factors. First, our study participants may not represent the general US population. Thus, our finding needs to be confirmed by future larger studies conducted in US population. Secondly, this difference could be due to different genetic background. Thirdly, the difference could be caused by regional environmental factors as our study was conducted in one state in the US. There was one previous study of Caucasian college students attending three Beijing Universities in China ¹⁶. We found the distribution of major types of TCM BC in this earlier study is also different from that in our study. However, the White college students recruited in this earlier study were mostly younger than 50 years old and lived in Beijing, a Northern city in China while most of the participants in our study were older than 50 years and lived in a single US state. Thus, the differences could be caused by age and regional environmental factors.

Another potential explanation for these discrepancies may lie in identifying how biomarkers of common diseases contribute to an individual’s TCM subtype. In our study, significant differences were found among the nine different BC types by various different biomarkers and vitals for cardiovascular disease. Some of these findings were expected, such as lower BMIs in the “healthy” Gentleness controls and the classically thinner Blood-stasis compositions ²⁸. However, the elevated BMIs in most other BC types, including the Phlegm-dampness and Yin-deficient types stand in contrast to findings in studies conducted in Chinese populations ²⁹. Again, the reason is unclear. For example, White, and in particular White Americans, peoples tend to have a higher overall BMI than Asian populations ³⁰. If BMI contributes to a person’s TCM BC type, then it may help to explain the differences in proportion of TCM BC subtypes between an American and Chinese populations. Taken a step further this could reflect differences in disease prevalence, such as cardiovascular disease, from one population to another, as previous studies found the incidence rates of cardiovascular disease and cancers (i.e. breast cancer, colorectal cancer and prostate cancer) are much higher in US populations than in Chinese populations ^31,32. Zhu et al. also identified which TCM subtypes were more represented among major chronic diseases, including hypertension, hyperlipidemia, and hyperglycemia. Thus, further understanding the underlying mechanism for the difference in TCM BC type between US and Chinese population may help to identify the novel risk factors contributing to common disease etiology.

Another primary research focus of this study was the GCRS, which represents an individual’s percent risk of cardiovascular disease (CVD) in 10 years, with a higher score necessarily translating to a higher percent risk. Again, our analyses revealed significant differences in the overall GCRS across BC types. Constitutions with the lowest average GCRS included Yang deficient (6.4), Blood-stasis (12.9), and Yin deficient (13.2), while Dampness-Heat (DH) (27.4) and Qi-deficient (21.9) recorded the highest GCRS.

Further subgroup analysis of the three low-CVD risk groups (Yin/Yang-deficient and BS) revealed a significantly lower average age and BMI, as well as a higher predominance of women, compared to both the Gentleness group and the remaining 5 groups. This biologically makes sense in the context of the Framingham model, which typically associated men, particularly older and more obese men, with increased CVD risk. Another finding was a significantly lower uric acid level among the low-CVD risk group. While uric acid was not a component of the initial Framingham study, more recent literature has reported on an association between uric acid and CVD risk, specifically an association between elevated uric acid (>5.5) and increased CVD risk ³³. Stratified analyses by sex revealed a loss of significance in the differences in BMI, GCRS, and Uric acid. Mediation analysis was also conducted, which revealed no significant effect mediation by sex. Thus, the loss of statistical significance when stratified by sex may be due to reduced sample size as we also found the patterns still remained in the stratified analysis.

The major limitation of the study was the sample size, specifically the sample sizes in each BC group, which limits the power of the analysis in stratified analysis. Secondly, the limitation is that not all parts of the survey were easily translatable to English from the original Chinese version due to the cultural differences, with some questions, such as those involving “sighing without reason” or “thick saliva” perhaps being less readily answered by our exclusively American population. However, this only appeared in limited survey questions which may not materially affect the directions of results. Also, this non-differential misclassification caused by the translation in cultural difference usually biases the results to the null. In other words, the true associations may be stronger than the ones we observed. Thirdly, the limitation is that we did not collect family history of cardiovascular disease and cannot adjust for this covariate in the current study. Further studies are warranted to examine whether family history of CVD contributes to the TCM BC types related to CVD risk. Finally, although the intra-class correlation coefficients ranging from 0.7 to 0.8 and the Cronbach’s alphas ranging from 0.44 to 0.72 are reasonable for reliability, these findings indicate that TCM BC types could vary during the three-month period in a study of White individuals in the US. Further studies are warranted to identify the factors contributing to the changes.

The majority of previous studies conducted in Mainland China which have investigated a similar topic have noted significant associations between CAD and particular TCM BC types, in particular Yin/Yang deficiency as well as Phlegm-dampness ^14,34. These findings have helped practitioners in China to better identify patients at risk for CVD and therefore initiate a preventive health regimen. Additional studies have also postulated associations between BC types and chemokine receptor/ligan expression, which would hold implications for a whole host of pathologies, including immunology and oncology. Translating these promising findings to an American population could be beneficial, given the prevalence of CVD in the United States.

However, our findings found although there are similarities, there are substantial differences between these two populations. Future studies should aim to understand the underlying mechanisms contributing to these differences, which may not only help to understand the underlying mechanism for TCM, but also help to identify novel factors or mechanisms for CVD risk, prevention and treatment.

In conclusion, future larger studies in US populations, particularly population-based studies including multiple racial/ethnic groups are warranted to confirm our findings. Further, future studies are also needed to examine whether combined use of BC type with the Framingham risk score can improve the Framingham risk score in predicting future risk of CAD in clinical settings.

Author contributions

Qi Dai: contributed to the hypothesis development; Qi Dai, Martha Shrubsole, Xiaolin Yin, Xiangzhu Zhu: contributed to the study design; Qi Dai, Martha Shrubsole, Xiaolin Yin, Xiangzhu Zhu, Xinqing Deng and Yevheniy Eugene Shubin: conducted the research; Lihua Shu, Xiangzhu Zhu, Jing Zhao: performed statistical analysis; Lihua Shu, Xiangzhu Zhu, Qi Dai, Martha Shrubsole drafted the manuscript; All the authors: contributed to the data interpretation and manuscript revision and read and approved the final manuscript.

Funding

This study was supported by R01 CA149633 from the National Cancer Institute, R01DK110166 from National Institute of Diabetes and Digestive and Kidney Diseases, Department of Health and Human Services as well as the Ingram Cancer Center Endowment Fund. Data collection, sample storage, and processing for this study were partially conducted by the Survey and Biospecimen Shared Resource, which is supported in part by P30CA68485. Clinical visits to the Vanderbilt at the Clinical Research Center were supported in part by the Vanderbilt CTSA grant UL1 RR024975 from NCRR/NIH. The parent study data were stored in Research Electronic Data Capture (REDCap), and data analyses (VR12960) were supported in part by the Vanderbilt Institute for Clinical and Translational Research (UL1TR000445).

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Author(s’) disclosure

The authors declare no competing interests.